270262-20-9

Upstream product

• 270262-17-4 (5R)-5-(tert-butyl-dimethylsilanyloxymethyl)-3-(4-methoxyphenyl)-2-oxo-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester 
• 287476-37-3 5-(tert-butyl-dimethyl-silanyloxymethyl)-3-iodo-2-oxo-2,5-dihydro-pyrrole-1-carboxylic acid tert-butyl ester 
• 126587-41-5 tert-butyl (2R)-2-({[tert-butyl(dimethyl)silyl]oxy}methyl)-5-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate 
• 5720-07-0 4-methoxyphenylboronic acid 
• 287476-38-4 (3S, 5R)-5-(tert-butyl-dimethylsilanyloxymethyl)-3-(4-methoxyphenyl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 270262-23-2 (2R, 4S)-4-(4-methoxyphenyl)-5-oxopyrrolidine-2-carboxylic acid benzyloxyamide 
• 270262-22-1 (3S, 5R)-5-benzyloxycarbamoyl-3-(4-methoxyphenyl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester 
• 270262-21-0 (2R, 4S)-4-(4-methoxyphenyl)-5-oxopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 

Relevant academic research and scientific papers

5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives

The present invention relates to a compound of the formula wherein R1, R2, R3 are as defined above, to pharmaceutical compositions and methods of treatment.

5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives

The present invention relates to a compound of the formula ???wherein R1, R2, R3 are as defined above, to pharmaceutical compositions and methods of treatment.